A randomized phase 2 trial comparing 3-h
โ
Stacy L. Moulder; Frankie A. Holmes; Anthony W. Tolcher; Peter Thall; Kristine B
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 168 KB
## Abstract ## BACKGROUND: This study was performed to compare efficacy and toxicity profiles of paclitaxel using 3โhour versus 96โhour infusion schedules. ## METHODS: Patients with metastatic breast cancer (MBC) were randomly assigned to receive paclitaxel starting at a dose of 250 mg/m^2^ intr